In March 2024, Synthimed took over the esteemed legacy established by Ind-Swift Laboratories since 1995. Our primary focus is on nurturing a strong domestic presence while strategically expanding into established regulated markets and emerging economies.

Each step forward stands as a testament to the dedication of our united team, whose unwavering commitment drives us toward new heights of achievement.
Equipped with cutting-edge manufacturing facilities, an independent R&D Centre, and a proven track record of regulatory approvals, Synthimed is dedicated to becoming a reliable partner in the global pharmaceutical arena. Our strengths lie in our capabilities for API development, production of finished dosage forms, non-infringing processes, and world-class facilities for contract manufacturing.

As we move forward, Synthimed remains steadfast in upholding the highest standards of quality and innovation, ensuring our ongoing contribution to the advancement of healthcare worldwide.

Pharmaceutical

Manufacturing

Life Sciences

Health Care

Synthimed Labs Private Limited

Shitij Ramesh Kale

Vikas Narendra

Mrinal Chandran

Hrishikesh Samant

Anurag Chaturvedi

Synthimed Labs Private Limited

Org chart

Similar companies